-
Alex Bodi utsedd till vicepresident för SCANDIC FINANCE-koncernen
-
تعيين أليكس بودي نائبًا لرئيس مجموعة SCANDIC FINANCE
-
SCANDIC FINANCEグループ、アレックス・ボディ氏を副社長に任命
-
بدء تجديد التسجيل في مدارس ريو دي جانيرو الحكومية للعام الدراسي 2027
-
SCANDIC FINANCE 그룹, 알렉스 보디 부사장 선임
-
تفجع لندن بوفاة اللاعب إيزيكيل ويليامز بعد اعتداء في ميلتون كينز
-
亞歷克斯・博迪獲任命為 SCANDIC FINANCE 集團副總裁
-
Алекса Боді призначено віцепрезидентом групи SCANDIC FINANCE
-
Алекс Боди назначен вице-президентом группы SCANDIC FINANCE
-
Alex Bodi appointed Vice President of SCANDIC FINANCE GROUP
-
Alex Bodi, numit vicepreședinte al grupului SCANDIC FINANCE
-
اختيار ملك وموكس نيتيروي للكرنفال 2027 في باريتو
-
Elon Musk jokes about moving businesses to space after US midterms
-
West Mercia Police opens 2027 cadet applications to Worcestershire teenagers
-
NHS to test blood screening designed to detect 13 cancers earlier
-
Worcestershire road closures announced for Remembrance Sunday events
-
Democrats near House takeover as voters judge Trump presidency
-
UBC professor describes police call after Galloway remark as act of care
-
Lethbridge submits interest in provincial ground ambulance contract
-
False voting claims spread rapidly during US Election Day
-
Trump Prepares Veto Strategy Amid Congressional Shift
-
The Cat in the Hat expands its stakes to cosmic scale in animated reboot
-
Lettermen co-founder Tony Butala dies at 87
-
Byron Donalds Elected Florida Governor, Becoming First Black Republican in Role
-
Byron Donalds wins Florida governor race and underscores Republican strength
-
James Talarico defeats Ken Paxton in historic Texas Senate result
-
Commentator predicts possible US strike on Iran as regional tensions rise
-
Goa plans relationship-readiness course amid concern over divorces
-
مستثمرون ومنظمات دولية يطالبون باتفاق عالمي لوقف تطوير الأسلحة ذاتية التشغيل
-
Manchester United climbs standings after 3-2 Champions League win over Roma
-
الهند تطبق هيكل تأمين المركبات الرباعي في ديسمبر المقبل
-
India introduces four-layer motor insurance choice from December 15
-
دمج القطاع الصحي الألماني في استراتيجية الدفاع الشامل
-
Mutual fund returns show shifting leaders across market-cap categories
-
Chervon Names Doug Palmer Vice President of Finance - Canada
-
BHEL wins Adani Power projects valued at up to ₹28,000 crore
-
تفاصيل بيع تذاكر نهائي كأس رابطة الأندية البيروفية بين كريستال وعلينزا أتلتيكو
-
IndiGo holds talks with Embraer over potential order for 100 aircraft
-
إيلون ماسك يسخر من هزيمة الجمهوريين بعد إنفاقه مئات الملايين
-
India seeks threefold increase in coal stocks to prevent summer power shortages
-
Indian companies report mixed second-quarter results on November 4
-
Indus Towers expands solar-powered network to 50,000 telecom sites
-
KKR secures Indian regulator approval for Gentari Renewables investment
-
Equitas Small Finance Bank rebounds after naming interim chief executive
-
Bharti Airtel revenue expected to grow at double-digit pace in second quarter
-
اعتقال مواطن ألباني في إيطاليا لانتهاكه حظر الترحيل
-
Titan quarterly profit seen rising as jewellery business drives growth
-
Indian crude-sensitive shares gain after 13% oil-price decline
-
Kuwait finance minister holds economic cooperation talks at COMCEC
-
رينو 5 الكهربائية: اختبار مدى 1000 كيلومتر من نيس إلى باريس
US Supreme Court asked to lift restrictions on abortion pill
The manufacturer of a widely used abortion pill asked the US Supreme Court on Friday to toss out a lower court ruling that would restrict access to the drug.
A US federal appeals court imposed restrictions last month on mifepristone but the ruling was put on hold pending an appeal to the Supreme Court.
Danco Laboratories, which markets mifepristone under the brand name Mifeprex, formally asked the nation's highest court on Friday to take up the case.
The Justice Department is expected to file a brief supporting Danco's request for the Supreme Court to review the ruling by the lower court.
Last month's ruling by a three-judge panel of the New Orleans-based 5th Circuit Court of Appeals would limit the use of mifepristone to the first seven weeks of pregnancy, instead of the current 10, and block it from being distributed by mail.
It would also require the abortion pill, which accounts for more than half of the abortions in the United States, to be prescribed by a doctor.
Anti-abortion groups are seeking to have mifepristone banned, claiming despite its long track record that it is unsafe. The case is the latest skirmish in the battle over reproductive rights in the United States.
The appeals court panel said the Food and Drug Administration (FDA), which approved the abortion pill in 2000 and made it more readily available in 2016, "failed to address several important concerns about whether the drug would be safe for the women who use it."
At a hearing in May, the judges pushed back against government arguments that the decision on whether to allow the use of mifepristone should be left to the FDA.
In its brief to the Supreme Court, Danco said the 5th Circuit ruling "upends FDA-approved conditions of use for Danco's drug Mifeprex.
"It does so at the request of a group of plaintiffs who do not prescribe or use the drug and whose real disagreement with FDA is that they oppose all forms of abortion," Danco said.
The case stems from an earlier ruling by a conservative US District Court judge in Texas that would have banned mifepristone.
The 5th Circuit blocked a ban on the abortion pill, but imposed the restrictions on access.
Conservatives wield a 6-3 majority on the Supreme Court, which overturned the constitutional right to abortion in a landmark ruling in June of last year.
Since then, some 20 states, mostly in the South and the Midwest, have prohibited abortion outright or restricted access while others, mainly on the coasts, have moved to protect it.
The FDA estimates that 5.6 million Americans have used mifepristone to terminate pregnancies since it was approved in 2000.
H.Nasr--SF-PST